NIH Supports Biosensor Development for GPCRs in Cancer
Bozeman, MT 9/30/3025 – Montana Molecular is celebrating the start of a new award from the National Cancer Institute at the National Institutes of Health. The company, based in Bozeman, Montana, is using a machine learning approach to design the structure...
Summer Days
Summer days: long hikes, water sports, hot dogs, fresh peaches, and plenty of sunscreen. How is it that our skin changes when exposed to sun, and why is it that those hot dogs on the grill smell so good? Two recent papers provide new glimpses of the molecular...
Montana Molecular Welcomes Chris Johnson as Senior Director of Operations
FOR IMMEDIATE RELEASE BOZEMAN, MT June 18, 2025 — Montana Molecular, a biopharma company with a history of innovation in designing novel fluorescent biosensors and gene delivery tools for drug discovery and cell biology research, is pleased to announce that Dr...
Psychedelic Drug Actions at Serotonin Receptors and the Path Towards Safer Treatments for Mental Disorders
How can we capture the therapeutic potential that psychedelic drugs have demonstrated against mental disorders while fading their risks in the discovery of new medicines? A key insight highlighted using fluorescent biosensors is that non-hallucinogenic...